GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » Price-to-Operating-Cash-Flow
中文

Ypsomed Holding AG (XSWX:YPSN) Price-to-Operating-Cash-Flow : 36.74 (As of Apr. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Ypsomed Holding AG's share price is CHF359.00. Ypsomed Holding AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was CHF9.77. Hence, Ypsomed Holding AG's Price-to-Operating-Cash-Flow Ratio for today is 36.74.

The historical rank and industry rank for Ypsomed Holding AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

XSWX:YPSN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.29   Med: 28.69   Max: 66.52
Current: 36.8

During the past 13 years, Ypsomed Holding AG's highest Price-to-Operating-Cash-Flow Ratio was 66.52. The lowest was 18.29. And the median was 28.69.

XSWX:YPSN's Price-to-Operating-Cash-Flow is ranked worse than
75.34% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.61 vs XSWX:YPSN: 36.80

Ypsomed Holding AG's Cash Flow from Operations per share for the six months ended in Sep. 2023 was CHF5.38. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was CHF9.77.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Ypsomed Holding AG was 18.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 35.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 17.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.00% per year.

During the past 13 years, Ypsomed Holding AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 144.30% per year. The lowest was -91.50% per year. And the median was 1.50% per year.


Ypsomed Holding AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Ypsomed Holding AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Price-to-Operating-Cash-Flow Chart

Ypsomed Holding AG Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.91 32.09 23.31 23.97 19.93

Ypsomed Holding AG Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 23.97 - 19.93 -

Competitive Comparison of Ypsomed Holding AG's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Price-to-Operating-Cash-Flow falls into.



Ypsomed Holding AG Price-to-Operating-Cash-Flow Calculation

Ypsomed Holding AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=359.00/9.771
=36.74

Ypsomed Holding AG's Share Price of today is CHF359.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was CHF9.77.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Ypsomed Holding AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (XSWX:YPSN) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (XSWX:YPSN) Headlines

No Headlines